Fundraising FoxFuture Planet Capital — 2026 Investments
6 investments dated 2026 · listed companies and verified rows first · show all
Captura develops Direct Ocean Capture technology using bipolar membrane electrodialysis to remove CO₂ from the upper ocean and atmosphere.
CleantechClimate TechDeep TechPasadena, US
Chengxiang Xiang(Founder)Bernard David(Chairman of the Board of Directors)inHarry Atwater(Founder)inCX Xiang(Chief Technology Officer & Co-Founder)inSteve Oldham(Chief Executive Officer)in
BoardMichael Wheeler(Director)in
Co-investorsEDP VenturesEni NextEquinor VenturesFREEFLOWHitachi VenturesMaersk Growth+4 more
Hydregen develops biocatalysis platform technologies that integrate into existing chemical manufacturing infrastructure, aiming to cut process costs by 40-50% while lowering energy use and carbon emissions.
BiotechCleantechNew MaterialsThame, GB
William Barton(Promoter)Kylie Vincent(Promoter)Holly Reeve(Executive Officer, Director)inMatthew Hodges(Executive Officer)inJose De Sousa(Director)Kevin Matthews(Director)in
Co-investorsClean Growth FundGenoa VenturesOxford Investment Opportunity Network (OION)Oxford Technology ManagementUK Innovation & Science Seed Fund
QuberTech is a UK-based biotechnology company developing biotech tools to produce natural rubber from alternative crops grown in controlled environments, aiming to deliver traceable and sustainable materials.
AgTechBiotechNew MaterialsNorwich, GB
Dr Ofir Meir(Co-founder & CEO)Dr Neil Clelland(Co-founder & CBO)in
Co-investorsSustainable VenturesUK Innovation & Science Seed Fund
Resurrect Bio develops more durable crop disease resistance by engineering plant immune receptors, combining plant molecular immunology, computational biology, AI, and high-throughput screening.
AgTechAI & Machine LearningBiotechLondon, GB
Cian Duggan(CEO & Co-Founder)inTolga Bozkurt(Co-Founder)inSophien Kamoun(Co-Founder)in
Co-investorsCalculus Capital Ltd.Growth Science VenturesSynBioVenUK Innovation & Science Seed FundAgFunderPymwymic
Spotlight Pathology develops AI-based diagnostic tools for pathology, particularly focused on blood cancer diagnosis and digital pathology services.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Martin(Co-Founder and Chief Technology Officer)Richard(Co-Founder and Chief Medical Officer)Sam Perona (Westgate)(Chief Executive Officer)in
Co-investorsDeepbridge CapitalUK Innovation & Science Seed FundRiver Capital
X Fuel develops alternative transport fuels using patented technologies that compete with fossil fuels on environmental and economic metrics.
Circular EconomyCleantechEnergyMobility & Transportation
Nicholas Ball, Ph.D.(Founder)in
Co-investorsAENULight RayOverlap HoldingsSOSVUnion Square Ventures (USV)Yes VC+1 more
.jpeg){kind=logo}
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.